IndraLab

Statements


| 1

reach
"Previous studies have shown that extracellular ATP requires the purinergic receptor P2X7R to induce inflammasome activation 26, and pre-treatment with the P2X7R antagonist AZ10606120 (AZ) indeed prevented pro-caspase-1 cleavage in response to LPS+ATP (XREF_FIG)."